Drawing for Serial No. 79275205

USPTO serial 79275205

Serial No. 79275205

Reviewed by CopyMark Law Group

Reg. 6382632Status 700Renewal
Filing date
Status date
Registration date
Jun 15, 2021
Examiner
LARKEY, MICHAEL M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79275205?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric J Maiers

Eric J Maiers Greenberg Traurig, LLP77 W. Wacker DriveSuite 3100Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical researchACTIVE—
005Medicines for human purpose, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseasesACTIVE—
035Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity servicesACTIVE—
042Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research services relating to DNA encoded library synthesis, namely, DNA analysis services for scientific research purposes; research services relating to DNA encoded library selection, namely, DNA screening for scientific research purposes; research services relating to DNA encoded library data analysis, namely, DNA screening for forensic research purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 15, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 8, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 10, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 29, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 30, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 30, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 15, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 15, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 13, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 26, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 26, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 30, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 30, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 10, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 10, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 24, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 24, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 24, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 24, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 4, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 6, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 14, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 13, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 6, 2020DOCKASSIGNED TO EXAMINER—
Jan 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 31, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance